Furthermore, the activity and function of NK cells was found to be suppressed in liver cancer patients from peripheral blood provided by healthy donors and liver cancer patients, and NKp30 on MDSCs was found to inhibit NK cells toxicity and cytokine release by binding to the NKp30 receptor in vitro study [81]. This evidence concerns the gene NCR3 and liver cancer.